Testing the effect of metacognitive therapy for insomnia

Metacognitive therapy for insomnia: a randomised controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN85892563

Enrollment

Registered

2020-07-13

Start date

2020-06-22

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia Mental and Behavioural Disorders Nonorganic insomnia

Interventions

Current interventions as of 30/08/2023: Patients receive up to 10 sessions of MCT. Assessment is made at pre, post and finally at 6 and 12 months follow-up with primary and secondary variables. Previ

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients suffering from insomnia as measured on the ISI

Exclusion criteria

Exclusion criteria: Patients are excluded if they: 1. Suffer from severe depression, anxiety or psychosis 2. Report any suicidality 3. Have sleep disruptive medical illnesses

Design outcomes

Primary

Measure	Time frame
Insomnia severity measured using Insomnia Severity Index (ISI) before treatment, after approximately 12 weeks treatment (10 sessions) and at 6 and 12 months follow-up	—

Secondary

Measure	Time frame
Anxiety and depressive symptoms measured using hospital anxiety and depression scale (HADS) before treatment, after approximately 12 weeks treatment (10 sessions) and at 6 and 12 months follow-up	—

Countries

Denmark

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026